Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;95:1054-1061

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reddy, V. M.
Right arrow Articles by Fineman, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reddy, V. M.
Right arrow Articles by Fineman, J. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Pulmonary Hypertension

(Circulation. 1997;95:1054-1061.)
© 1997 American Heart Association, Inc.


Articles

Post–Cardiopulmonary Bypass Pulmonary Hypertension in Lambs With Increased Pulmonary Blood Flow

A Role for Endothelin 1

V. Mohan Reddy, MD; Karen D. Hendricks-Munoz, MD; Hiranya A. Rajasinghe, MD; Edwin Petrossian, MD; Frank L. Hanley, MD; Jeffrey R. Fineman, MD

the Departments of Cardiothoracic Surgery (V.M.R., H.A.R., E.P., F.L.H.) and Pediatrics (J.R.F.), University of California, San Francisco, and the Department of Pediatrics (K.D.H.-M.), New York University.

Correspondence to Jeffrey R. Fineman, MD, University of California, San Francisco, 505 Parnassus Ave, Box 0106, M-680, San Francisco, CA 94143-0106.

Background After cardiopulmonary bypass (CPB), pulmonary hypertension and its associated increased vascular reactivity are a major source of morbidity, particularly for children with increased pulmonary blood flow. Although post-CPB pulmonary hypertension is well described, its mechanisms remain incompletely understood. Plasma levels of endothelin 1, a potent vasoactive substance implicated in pulmonary hypertension, are increased after CPB. The purpose of the present study was threefold: to characterize the changes in pulmonary vascular resistance and vascular reactivity induced by hypothermic CPB; to investigate the effects of preexisting increased pulmonary blood flow on these changes; and to better define the role of endothelin 1 in the pathogenesis of post-CPB pulmonary hypertension.

Methods and Results Vascular pressures and blood flows were monitored in 14 1-month-old lambs with increased pulmonary blood flow (after in utero placement of an aortopulmonary shunt) and 6 age-matched control lambs. During the 2-hour study period after 105.3±20.6 minutes of hypothermic CPB, the increase in pulmonary vascular resistance was significantly augmented in lambs with increased pulmonary blood flow compared with control lambs (P<.05). Pretreatment with PD 145065 (a nonselective endothelin receptor blocker; 50 µg·kg-1·min-1) completely blocked this increase in pulmonary vascular resistance and blocked the increase in pulmonary vascular resistance in response to acute alveolar hypoxia after CPB (96.3±88.5% versus -9.7±16.4%; P<.05). Plasma endothelin 1 levels increased after CPB in all lambs.

Conclusions Preexisting increased pulmonary blood flow alters the response of the pulmonary circulation to hypothermic CPB; the increase in pulmonary vascular resistance induced by CPB is augmented in lambs with increased pulmonary blood flow. Pretreatment with endothelin 1 receptor blockers eliminated the increase in pulmonary vascular resistance and the pulmonary vasoconstricting response to alveolar hypoxia, suggesting a role for endothelin 1 in post-CPB pulmonary hypertension. Endothelin 1 receptor blockers may decrease morbidity in children at risk for pulmonary hypertension after surgical repair with CPB and warrants further study.


Key Words: hypertension, pulmonary • cardiopulmonary bypass • endothelin




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Oishi, A. Azakie, C. Harmon, R. K. Fitzgerald, A. Grobe, J. Xu, K. Hendricks-Munoz, S. M. Black, and J. R. Fineman
Nitric oxide-endothelin-1 interactions after surgically induced acute increases in pulmonary blood flow in intact lambs
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1922 - H1932.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Pearl, S. M. Schwartz, D. P. Nelson, C. J. Wagner, J. M. Lyons, S. M. Bauer, and J. Y. Duffy
Preoperative glucocorticoids decrease pulmonary hypertension in piglets after cardiopulmonary bypass and circulatory arrest
Ann. Thorac. Surg., March 1, 2004; 77(3): 994 - 1000.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Mathieu, J. Dupuis, M. Carrier, P. Cernacek, M. Pellerin, L. P. Perrault, R. Cartier, J. Taillefer, and L. C. Pelletier
Pulmonary metabolism of endothelin 1 during on-pump and beating heart coronary artery bypass operations
J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1137 - 1142.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
B Prendergast, D E Newby, L E Wilson, D J Webb, and P S Mankad
Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery
Heart, October 1, 1999; 82(4): 505 - 508.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. Petrossian, A. J. Parry, V. M. Reddy, G. P. Akkersdijk, D. M. McMullan, L. Thompson, K. D. Hendricks-Munoz, H. Hallak, F. L. Hanley, and J. R. Fineman
ENDOTHELIN RECEPTOR BLOCKADE PREVENTS THE RISE IN PULMONARY VASCULAR RESISTANCE AFTER CARDIOPULMONARY BYPASS IN LAMBS WITH INCREASED PULMONARY BLOOD FLOW
J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 314 - 323.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. M. Reddy, D. B. McElhinney, H. A. Rajasinghe, J. R. Liddicoat, K. Hendricks-Munoz, J. R. Fineman, and F. L. Hanley
ROLE OF THE ENDOTHELIUM IN PLACENTAL DYSFUNCTION AFTER FETAL CARDIAC BYPASS
J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 343 - 351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Fineman, Y. Takahashi, C. Roman, and R. I. Clyman
Endothelin-receptor blockade does not alter closure of the ductus arteriosus
Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1620 - H1626.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Ochiai, S. Morita, Y. Tanoue, Y. Kawachi, R. Tominaga, and H. Yasui
Effects of amrinone, a phosphodiesterase inhibitor, on right ventricular/arterial coupling immediately after cardiac operations
J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 139 - 147.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Bando, P. Vijay, M. W. Turrentine, T. G. Sharp, L. J. Means, G. J. Ensing, B. J. Lalone, Y. Sekine, L. Szekely, and J. W. Brown
Dilutional And Modified Ultrafiltration Reduces Pulmonary Hypertension After Operations For Congenital Heart Disease: A Prospective Randomized Study
J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 517 - 527.
[Abstract] [Full Text]